Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2010 Jul;5(4):298-304.
doi: 10.1097/COH.0b013e32833a6c32.

Highly active antiretroviral treatment as prevention of HIV transmission: review of scientific evidence and update

Reuben Granich  1 , Siobhan Crowley, Marco Vitoria, Caoimhe Smyth, James G Kahn, Rod Bennett, Ying-Ru Lo, Yves Souteyrand, Brian Williams
Affiliations
Review

Highly active antiretroviral treatment as prevention of HIV transmission: review of scientific evidence and update

Reuben Granich et al. Curr Opin HIV AIDS. 2010 Jul.

Abstract

Purpose of review: An estimated 33 million people are living with HIV and universal access remains a dream for millions of people. By the end of year 2008, four million people were on treatment; however, over five million needed treatment, and in 2007, there were 2.7 million new infections. Without significant improvement in prevention, we are unlikely to meet universal access targets including the growing demand for highly active antiretroviral treatment (HAART). This review examines HAART as a potential tool for preventing HIV transmission.

Recent findings: We discuss recent scientific evidence regarding the treatment and prevention gap, importance viral load and HIV transmission, HAART and HIV transmission, when to start, HIV counseling and testing, modeling results and next steps.

Summary: HAART has considerable treatment and prevention benefits and it needs to be considered as a key element of combination prevention. To explore HAART as an effective prevention strategy, we recommend further evaluation of human rights and ethical considerations, clarification of research priorities and exploration of feasibility and acceptability issues.

PubMed Disclaimer

Conflict of interest statement

Conflict of interests

None of the authors have conflicts of interest to declare.

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Barre-Sinoussi F, Chermann JC, Rey F, Nugeyre MT, Chamaret S, Gruest J, Dauguet C, Axler-Blin C, Vezinet-Brun F, Rouzioux C, et al. Isolation of a T-lymphotropic retrovirus from a patient at risk for acquired immune deficiency syndrome (AIDS) Science. 1983;220:868–871. - PubMed
    1. WHO. Towards Universal Access: Scaling up priority HIV/AIDS interventions in the health sector 2008
    1. WHO. Global tuberculosis control : epidemiology, strategy, financing WHO/HTM/TB/2009.411. Geneva, Switzerland: 2009. http://www.who.int/tb/publications/global_report/2009/pdf/full_report.pdf. Yearly WHO surveillance report that describes global TB control progress.
    1. UNAIDS. Financial resources required to achieve universal access to HIV prevention, treatment, care and support. Geneva, Switzerland: 2007. http://data.unaids.org/pub/Report/2007/20070925_advocacy_grne2_en.pdf.
    1. [March 13, 2010];Global Issues: Social, Political, Economic and Environmental Issues That Affect Us All. http://www.globalissues.org/article/768/global-financial-crisis#Thefinan....

MeSH terms

Substances